Josep Llorens is VP at HAEMONETICS CORP (HAE). They have made 10 open-market trades across 1 company since 2019, most recently 2024-05-28.
CIK 0001750812
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HAE | 35,450 | $4.5M |
Shares reported on the most recent Form 4, priced at the 2024-05-29 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HAE | SELL · 10b5-1 | 2024-05-17 | 2024-05-21 | $94.96 | $344K | -3.1% | -2.6% | -14.7% |
| HAE | SELL · 10b5-1 | 2024-05-16 | 2024-05-17 | $96.14 | $148K | -11.0% | -10.0% | -22.2% |
| HAE | SELL · 10b5-1 | 2023-07-18 | 2023-07-20 | $90.00 | $444K | -0.6% | -7.9% | -2.2% |
| HAE | SELL | 2023-01-23 | 2023-01-25 | $90.00 | $215K | -3.3% | -13.0% | -8.3% |
| HAE | SELL | 2022-09-06 | 2022-09-07 | $73.78 | $7K | +6.0% | +2.9% | +13.9% |
| HAE | SELL | 2022-05-19 | 2022-05-23 | $59.10 | $168K | +6.2% | +0.3% | +25.8% |
| HAE | SELL | 2022-05-16 | 2022-05-18 | $56.10 | $6K | +7.5% | +3.3% | +29.7% |
| HAE | SELL | 2021-09-07 | 2021-09-09 | $64.61 | $6K | +7.1% | +1.3% | -15.7% |
| HAE | SELL | 2021-05-19 | 2021-05-20 | $55.19 | $7K | -1.9% | +11.3% | +2.9% |
| HAE | SELL | 2021-05-17 | 2021-05-18 | $55.97 | $6K | +1.7% | +12.7% | +5.9% |
| HAE | SELL | 2020-09-08 | 2020-09-10 | $88.71 | $9K | -8.8% | +5.3% | +24.3% |
| HAE | SELL | 2020-05-15 | 2020-05-19 | $100.44 | $11K | +5.8% | -17.4% | -17.7% |
| HAE | SELL | 2019-09-05 | 2019-09-09 | $129.94 | $13K | +6.6% | +3.3% | -2.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.